Advertisement banner
Advertisement

Condia Insider: Why Venture Capital alone can’t save African Healthtech

African healthtech startups struggle to scale as funding falls and government support lags. Venture capital alone isn’t enough to fix the system
4 minute read
Condia Insider: Why Venture Capital alone can’t save African Healthtech
Photo: Source: Getty Images

🍔 Quick Bite: Africa’s healthtech dream keeps running into old problems: weak policy, poor funding, and shaky infrastructure. Without government muscle, even the best startups are struggling to stay alive.

🧠 The Breakdown

In October 2024, government officials from across Africa convened in Kigali for a healthtech policy summit. Ministers pledged collaboration, startups presented bold solutions, and multilateral organisations offered support. By the end, participants charted an “implementation roadmap with defined goals for the next year and beyond.” Some months earlier, MedSaf, a Nigerian healthtech backed by Y Combinator and over $7 million in funding, shut down, citing “mounting debts and significant unpaid receivables from hospitals.”

That contrast captures the central tension of African healthtech: bold ambition on one hand, fragility on the other. It raises the question: can healthtech flourish on venture capital alone, or does it demand deeper government backing?

Read the full story

This story is for Condia Insiders only.

Keep reading free. Join the community at the forefront of African tech.

Last updated: October 27, 2025

Advertisement